Mechanism of action of flibanserin, a multifunctional serotonin agonist and antagonist (MSAA), in hypoactive sexual desire disorder-Reference-Cited by-同舟云学术

Mechanism of action of flibanserin, a multifunctional serotonin agonist and antagonist (MSAA), in hypoactive sexual desire disorder

Published:2015-02 Issue:1 Volume:20 Page:1-6
ISSN:1092-8529
Container-title:CNS Spectrums
language:en
Short-container-title:CNS Spectr.

Author:

Stahl Stephen M.

Abstract

Flibanserin is a novel multifunctional serotonin agonist and antagonist (MSAA) that improves sexual functioning in premenopausal women who suffer from reduced sexual interest and desire.

Publisher

Cambridge University Press (CUP)

Subject

Psychiatry and Mental health,Clinical Neurology

Reference25 articles.

1. The Psychopharmacology of Sex, Part 2: Effects of Drugs and Disease on the 3 Phases of Human Sexual Response

2. Dopaminergic modulation of limbic and cortical drive of nucleus accumbens in goal-directed behavior

3. Dopamine release induced by atypical antipsychotics in prefrontal cortex requires 5-HT1A receptors but not 5-HT2A receptors

4. Research Domain Criteria (RDoC): Toward a New Classification Framework for Research on Mental Disorders

5. The last Diagnostic and Statistical Manual (DSM): replacing our symptom-based diagnoses with a brain circuit-based classification of mental illnesses

Cited by 151 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Sexual Desire and Pharmacologic Management;Obstetrics and Gynecology Clinics of North America;2024-06

2. Advances in drug design and therapeutic potential of selective or multitarget 5‐HT1A receptor ligands;Medicinal Research Reviews;2024-05-29

3. FLIBANSERIN;Prescriber's Guide;2024-04-18

4. Neurologic Aspects of Sexual Function;Kaufman's Clinical Neurology for Psychiatrists;2023

5. Modeling Female Sexual Desire: An Overview and Commentary;Sexual Disorders and Dysfunctions [Working Title];2022-10-25